Acepodia

Alameda, United States

Acepodia is a therapeutics company that employs flexible therapeutic design to treat cancer.

$100.0M raised

Jun 2023

Series D

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Acepodia raised?

Acepodia has raised $100.0M in total funding. The most recent round was Series D. The last funding was announced in June 2023.

Who are Acepodia's investors?

Acepodia's investors include 8VC, DEFTA Partners, CDIB Capital, Ridgeback Capital, TopTaiwan.

Where is Acepodia headquartered?

Acepodia is headquartered in Alameda, United States.

What does Acepodia do?

Acepodia is a therapeutics company that employs flexible therapeutic design to treat cancer.

What stage is Acepodia at?

Acepodia is at the Series D stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 6, 2023.

MLA

"Acepodia — Funding & Investors." VCBacked, June 6, 2023, https://www.vcbacked.co/company/acepodia. Accessed July 2, 2026.

APA

VCBacked. (2023). Acepodia — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/acepodia

Wikipedia (cite web)

{{cite web |title=Acepodia — Funding & Investors |url=https://www.vcbacked.co/company/acepodia |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 6, 2023.